Syneos Health (SYNH) Tops Q4 EPS by 2c; Guides FY23 Below the Street

Syneos Health (NASDAQ: SYNH) reported Q4 EPS of $1.23, $0.02 better than the analyst estimate of $1.21. Revenue for the quarter came in at $1.36 billion versus the consensus estimate of $1.29 billion.

GUIDANCE:

Syneos Health sees Q1 2023 EPS of $3.26-$3.53, versus the consensus of $3.89. ObsEva SA sees Q1 2023 revenue of $4.975-5.175 billion, versus the consensus of $5.13 billion.

For earnings history and earnings-related data on Syneos Health (SYNH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c